During the past decade, UCSD Medical Center conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 102 clinical trials were completed, i.e. on average, 74.5% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 61 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSD Medical Center" #1 sponsor was "University of California, San Diego" with 60 trials, followed by "Abbott Medical Devices" with 9 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored and "Pfizer" with 9 trials sponsored. Other sponsors include 220 different institutions and companies that sponsored additional 163 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSD Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 7 trials as a collaborator, "National Marrow Donor Program" with 7 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator. Other collaborators include 167 different institutions and companies that were collaborators in the rest 135 trials.

According to Clinical.Site data, the most researched conditions in "UCSD Medical Center" are "HIV Infections" (17 trials), "Coronary Artery Disease" (9 trials), "Heart Failure" (8 trials), "Ulcerative Colitis" (7 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "UCSD Medical Center" in a lesser frequency.

Most popular intervention types in "UCSD Medical Center" are "Drug" (189 trials), "Device" (59 trials), "Other" (35 trials), "Procedure" (30 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "Bosentan" (3 trials), "Etrolizumab" (3 trials), "Gantenerumab" (3 trials) and "Matching Placebo (Gantenerumab)" (3 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Medical Center" are 295 trials for "All" genders, 21 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "UCSD Medical Center". undefined are not yet recruiting, 40 are recruiting, 23 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 191 completed trials in UCSD Medical Center, 2 suspended trials, and 42 terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Medical Center, 29 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 69 trials that are defined as “Not Applicable".